A new red line

November 1999
Discover;Nov99, Vol. 20 Issue 11, p40
Reports on researches on the regeneration of stem cells for cancer patients who undergo chemotherapy.


Related Articles

  • Front & Back Matter.  // Cells Tissues Organs;Dec2018, Vol. 206 Issue 1/2, pN.PAG 

    No abstract available.

  • Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analyses. Weaver, C H; West, W H; Schwartzberg, L S; Alberico, T; Leff, R; Greco, F A; Hainsworth, J; Birch, R; McAneny, B; Magee, M; Raefsky, E; Kalman, L; Buckner, C D // Bone Marrow Transplantation;4/1/97, Vol. 19 Issue 7, p661 

    We investigated the outcomes of patients with breast cancer undergoing induction chemotherapy, mobilization of peripheral blood stem cells (PBSC) and high-dose chemotherapy (HDC) with PBSC infusion. One hundred and fourteen patients with untreated stage IV breast cancer, with a median age of 46...

  • IN THIS ISSUE.  // JNCI: Journal of the National Cancer Institute;Jan2012, Vol. 104 Issue 1, p1 

    An introduction to the journal is presented including an editorial on the use of high-dose chemotherapy with autologous stem cell transplantation for follicular lymphoma, one on accelerated partial breast irradiation using brachytherapy, and another on associations between high soy and legume...

  • Use of Filgrastim for Stem Cell Mobilisation and Transplantation in High-Dose Cancer Chemotherapy. Anderlini, P.; Champlin, R. // Drugs;2002 Supplement 1, Vol. 62 Issue 9, p79 

    Myeloablative or high-dose chemotherapy regimens utilise doses that are significantly greater than those used in standard treatments. The neutropenia caused by these high-dose therapies can be associated with an increased incidence of bacterial and fungal infections and remains an important...

  • Current Trends in Chemotherapy for Metastatic Nonseminomatous Testicular Germ Cell Tumors. Bokemeyer // Oncology;1998, Vol. 55 Issue 3, p177 

    With the introduction of cisplatin-based chemotherapy, metastatic testicular cancer represents a model for a highly curable malignant disease. Approximately 70–80% of patients achieve a durable remission following chemotherapy ± secondary surgery of residual tumors. With the...

  • Intensive Treatment and Autologous Transplant for Mantle Cell Lymphoma. Artz, Andrew S. // Clinical Oncology Alert;Nov2008, Vol. 24 Issue 11, p81 

    Long-term disease control remains an elusive target for mantle cell lymphoma (MCL), even after aggressive therapy. The Nordic Lymphoma Group treated 160 patients younger than 65 years of age on a phase II protocol using rituximab and CHOP alternating with rituximab and high-dose cytarabine...

  • Granulocytic sarcoma: a systematic review. Yilmaz, Asu Fergun; Saydam, Guray; Sahin, Fahri; Baran, Yusuf // American Journal of Blood Research;2013, Vol. 3 Issue 4, p265 

    Granulocytic sarcoma also called myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is a rare entity, and mostly accompanied by acute myeloid leukemia. It is observed during the course of myeloproliferative disorders especially in chronic myeloid leukemia and...

  • Cancer Stem Cells: The Emerging Challenge of Drug Targeting. Besançon, Roger; Valsesia-Wittmann, Sandrine; Puisieux, Alain; de Fromentel, Claude Caron; Maguer-Satta, Veronique // Current Medicinal Chemistry;Feb2009, Vol. 16 Issue 4, p394 

    Stem cells are defined by their unique property to self-renew and starting from one single cell to generate all the different progenies required for tissue regeneration. In adults, stem cells are still present in the majority of tissues and organs where they are responsible for continuous organs...

  • High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB). Benesch, M; Bartelheim, K; Fleischhack, G; Gruhn, B; Schlegel, P G; Witt, O; Stachel, K D; Hauch, H; Urban, C; Quehenberger, F; Massimino, M; Pietsch, T; Hasselblatt, M; Giangaspero, F; Kordes, U; Schneppenheim, R; Hauser, P; Klingebiel, T; Frühwald, M C // Bone Marrow Transplantation;Mar2014, Vol. 49 Issue 3, p370 

    A retrospective analysis of data from the European Rhabdoid Registry (EU-RHAB) was performed to describe the outcome of children with atypical teratoid/rhabdoid tumors (AT/RT) who underwent high-dose chemotherapy (HDCT) with auto-SCT. Nineteen patients (male, n=15; median age at diagnosis 21...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics